Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Apr '25 Apr 29, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Market Capitalization	301	426	283	368	950	-	Upgrade
Market Cap Growth	50.74%	50.74%	-23.21%	-61.22%	-	-	Upgrade
Enterprise Value	-25	228	151	142	583	-	Upgrade
Last Close Price	4.95	6.94	5.65	7.61	20.42	-	Upgrade
PS Ratio	4.84	5.64	-	-	-	-	Upgrade
PB Ratio	1.37	1.91	1.58	1.36	2.73	-	Upgrade
P/TBV Ratio	1.37	1.91	1.58	1.36	2.73	-	Upgrade
P/FCF Ratio	8.01	11.22	-	-	-	-	Upgrade
P/OCF Ratio	7.25	10.15	-	-	-	-	Upgrade
EV/Sales Ratio	-	3.01	-	-	-	-	Upgrade
EV/FCF Ratio	-	6.00	-	-	-	-	Upgrade
Debt / Equity Ratio	0.19	0.19	0.26	0.17	-	-	Upgrade
Debt / FCF Ratio	1.12	1.12	-	-	-	-	Upgrade
Asset Turnover	0.20	0.20	-	-	-	-	Upgrade
Quick Ratio	2.37	2.37	5.00	10.58	20.80	1.43	Upgrade
Current Ratio	2.40	2.40	5.07	10.79	20.96	1.49	Upgrade
Return on Equity (ROE)	-36.15%	-36.15%	-60.07%	-35.06%	-40.35%	-277.72%	Upgrade
Return on Assets (ROA)	-13.66%	-13.66%	-27.72%	-19.82%	-21.92%	-57.90%	Upgrade
Return on Capital (ROIC)	-20.65%	-20.65%	-32.95%	-21.09%	-24.85%	-131.69%	Upgrade
Earnings Yield	-23.88%	-17.05%	-47.85%	-29.46%	-7.79%	-	Upgrade
FCF Yield	12.48%	8.91%	-22.22%	-28.61%	-7.28%	-	Upgrade
Buyback Yield / Dilution	-43.80%	-43.80%	-8.83%	-88.91%	-1548.09%	-7.11%	Upgrade

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q